Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation (Companion Faculty Lecture)

Featuring a slide presentation and related discussion from Dr Edward Garon, including the following topics: • Immune checkpoint inhibitor therapy for treatment-naïve advanced non-small cell lung cancer (NSCLC) without an actionable mutation (0:00) • Duration of immunotherapy in the frontline setting for NSCLC with no targetable mutation (13:43) • New treatment strategies for relapsed or refractory NSCLC with no targetable mutation (16:25) • Management of antibody-drug conjugate-associated toxicity (19:08) • Activity of antibody-drug conjugates alone or in combination with anti-PD-1 antibodies (26:18) CME information and select publications